Corti opens up its clinical-AI stack to launch as Europe’s regulatory bill mounts
The Copenhagen-based company says its Symphony model outperformed OpenAI in HealthBench Professional, and offers credits and regulatory assistance to innovators building healthcare AI around the world.
Corti, a clinical AI company based in Copenhagen, has launched the first asymmetric accelerator in health and life sciences, opening the Symphony model to its founders worldwide at a time when regulatory costs for building medical AI in Europe are not yet high.
The company said on Tuesday that Symphony, its advanced clinical model, has surpassed OpenAI HealthBench Professionala virtual doctor chat benchmark released last month by OpenAI and its ChatGPT for Clinicians product.
The new Accelerated Startup program offers up to $5,000 in credits for the entire Symphony stack, which includes agents, medical coding, speech-to-text, and text production and, according to the company, trained with more than 1.5 million hours of clinical audio.
💜 for EU tech
The latest talk from the EU tech scene, a story from our genius founder Boris, and some incredible AI art. It’s free, every week, in your inbox. Register now!
Participants also get direct time with Corti’s clinical and regulatory team on EU AI Act, MDR, and data residency questions, founder-led roadmap webinars, and invitations to Corti events in New York, Copenhagen, London, and Berlin.
Applications are open today on a rolling basis for one week. There is no pitch process and no equity component, and the program is open to pre-seed through Series B companies in healthcare, clinical workflow, or adjacent life sciences.
The presentation sits within the sharp background of the control. In April, OpenAI free clinical AI released to all certified American physicians, nurses, physician assistants, and pharmacists.
After a week, Open evidencea clinical AI search platform valued at $12 billion and used daily by nearly 40% of US doctors, has withdrawn from the UK and EU, citing regulatory uncertainty under the EU AI Act.
Tthe obligations of the high-risk system after that decision come into force on 2 August 2026, although AI embedded in CE-marked medical devices regulated under the MDR or IVDR has a different timeline for Article 6(1) currently scheduled for August 2, 2027.
The European structural cost layer is another part of Corti’s argument. EU MDR certificate only it costs developers between €200,000 and €600,000 per device and takes 12 to 18 months, according to navigation industry guidelines.
Galen Growth’s Q1 2026 Analysis shows European digital health funding includes in large rounds, of the latest stage, where investors are more interested in companies that can show clinical evidence and integration of work flow instead of subject performance.
“The future of healthcare AI will not be built by a single company. It will be built by thousands of teams, each with deep knowledge of a specific area of care, workflow, or patient population,” said Andreas Cleve, founder and CEO of Corti.
“Our job is to give those developers a starting point: the best clinical AI model, the evidence base behind it, and the path to production that we’ve already taken with managed health systems. So they can focus only on what they can do, the workflow, the patient population, the problem they really understand.”
Among the development teams already building on Corti is Aisel Health, a European start-up focused on cognitive performance.
“Psychiatrists are a rare and special resource,” said Augusta Klingsten Peytz, founder and CEO of Aisel. “
They should focus on one thing only: making clinical decisions, everything else needs to go. Yet today, most of a psychiatrist’s time is spent not on clinical decision-making, but on the administrative and repetitive work flow that surrounds us.
By using Corti, we at Aisel can focus on delivering a unique cognitive workflow that helps clinicians re-energize, rather than rebuilding the clinical grade foundation from the ground up.”
Corti has raised $100 million to date, with offices in Copenhagen, New York and London. Its Symphony of Medical Coding release in April claimed 25% more accuracy than OpenAI and Anthropic on ACI-BENCH and MDACE, two medical coding benchmarks, and the company says the stack powers AI for systems that serve more than 100 million patients a year, including the NHS.
The premise of this plan, in Corti’s formulation, is that the conditions that make Europe difficult for horizontal model providers are the conditions that vertical AI players are built for. Applications are open from today.
